Stockscreener 앱 받기
2.33
1.27%
-0.03
시간 외 거래:
2.31
-0.02
-0.86%
전일 마감가:
$2.36
열려 있는:
$2.35
하루 거래량:
672.98K
Relative Volume:
0.48
시가총액:
$389.32M
수익:
-
순이익/손실:
$-274.18M
주가수익비율:
-0.9193
EPS:
-2.5346
순현금흐름:
$-198.33M
1주 성능:
-12.08%
1개월 성능:
+29.44%
6개월 성능:
+208.77%
1년 성능:
-75.95%
1일 변동 폭
$2.28
$2.42
1주일 범위
$2.28
$2.79
52주 변동 폭
$0.611
$11.57
Neumora Therapeutics Inc Stock (NMRA) Company Profile
명칭
Neumora Therapeutics Inc
전화
(857) 760-0900
주소
260 ARSENAL PLACE, SUITE 1, WATERTOWN
NMRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NMRA
Neumora Therapeutics Inc
|
2.33 | 394.33M | 0 | -274.18M | -198.33M | -2.5346 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2025-09-16 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-04-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-03-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-03-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-03-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-01-02 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-10-01 | 개시 | H.C. Wainwright | Buy |
| 2024-07-22 | 개시 | Needham | Buy |
| 2024-07-08 | 개시 | Mizuho | Outperform |
| 2023-12-12 | 개시 | Deutsche Bank | Hold |
| 2023-10-10 | 개시 | BofA Securities | Buy |
| 2023-10-10 | 개시 | Guggenheim | Buy |
| 2023-10-10 | 개시 | JP Morgan | Overweight |
| 2023-10-10 | 개시 | RBC Capital Mkts | Outperform |
| 2023-10-10 | 개시 | Stifel | Buy |
| 2023-10-10 | 개시 | William Blair | Outperform |
모두보기
Neumora Therapeutics Inc 주식(NMRA)의 최신 뉴스
Neumora Issues Shares Following Loan Conversion Notice - TipRanks
How Neumora Therapeutics Inc. stock trades before earningsPortfolio Update Report & Weekly Setup with ROI Potential - newser.com
How Neumora Therapeutics Inc. stock reacts to oil pricesJuly 2025 Earnings & AI Enhanced Market Trend Forecasts - newser.com
Is Neumora Therapeutics Inc. stock oversold or undervalued2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Chart overlay techniques for tracking Neumora Therapeutics Inc.Trade Entry Summary & Proven Capital Preservation Methods - newser.com
What momentum shifts mean for Neumora Therapeutics Inc.Quarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Can Neumora Therapeutics Inc. stock maintain growth trajectoryGlobal Markets & Accurate Trade Setup Notifications - newser.com
How to build a custom watchlist for Neumora Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - newser.com
Is Neumora Therapeutics Inc. stock a safe investment in uncertain marketsIndex Update & Risk Controlled Daily Trade Plans - newser.com
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com India
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Neumora Therapeutics (NASDAQ:NMRA) Price Target Raised to $3.00 at Stifel Nicolaus - MarketBeat
Stifel raises Neumora Therapeutics stock price target to $3 from $2 - Investing.com Canada
Stifel Maintains Neumora Therapeutics (NMRA) Hold Recommendation - Nasdaq
Neumora Therapeutics price target raised to $3 from $2 at Stifel - TipRanks
Can a trend reversal in Neumora Therapeutics Inc. lead to recoveryMarket Activity Recap & Daily Volume Surge Signals - newser.com
Neumora Therapeutics (NASDAQ:NMRA) Insider Sells 114,703 Shares - MarketBeat
What risks investors should watch in Neumora Therapeutics Inc. stockMarket Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
Published on: 2025-11-14 18:32:34 - newser.com
Why Neumora Therapeutics Inc. stock is a must watch in 2025Market Trend Report & Safe Capital Growth Tips - newser.com
Regression analysis insights on Neumora Therapeutics Inc. performanceQuarterly Growth Report & Technical Buy Zone Confirmations - newser.com
HC Wainwright Has Optimistic Outlook of NMRA FY2025 Earnings - MarketBeat
Neumora Therapeutics Inc (NMRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):